Patrick C D'Haese Selected Research

Adenine

1/2022	Sclerostin Protects Against Vascular Calcification Development in Mice.
10/2020	Renoprotective effects of sucroferric oxyhydroxide in a rat model of chronic renal failure.
1/2018	Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
11/2016	Can Intestinal Phosphate Binding or Inhibition of Hydroxyapatite Growth in the Vascular Wall Halt the Progression of Established Aortic Calcification in Chronic Kidney Disease?
12/2015	Disturbances in Bone Largely Predict Aortic Calcification in an Alternative Rat Model Developed to Study Both Vascular and Bone Pathology in Chronic Kidney Disease.
6/2013	Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
9/2010	Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats.
6/2009	Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick C D'Haese Research Topics

Disease

23	Chronic Kidney Failure (Chronic Renal Failure) 07/2021 - 03/2003
22	Vascular Calcification 01/2022 - 05/2006
17	Chronic Renal Insufficiency 04/2022 - 01/2009
14	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 11/2021 - 03/2003
11	Renal Insufficiency (Renal Failure) 01/2021 - 01/2003
9	Hyperphosphatemia 07/2021 - 06/2003
6	Osteoporosis 01/2020 - 08/2003
6	Nephrocalcinosis 01/2015 - 10/2005
6	Osteomalacia 03/2005 - 01/2003
5	Inflammation (Inflammations) 01/2022 - 01/2017
5	Hyperparathyroidism 01/2019 - 05/2003
5	Fibrosis (Cirrhosis) 12/2018 - 01/2010
5	Ischemia 12/2018 - 10/2005
5	Uremia 06/2013 - 01/2007
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2012
4	Acute Kidney Injury (Acute Renal Failure) 12/2018 - 09/2012
4	Secondary Hyperparathyroidism 04/2015 - 03/2003
4	Bone Diseases (Bone Disease) 01/2007 - 06/2003
3	Kidney Diseases (Kidney Disease) 05/2020 - 04/2016
3	Postmenopausal Osteoporosis 01/2019 - 05/2004
3	Hyperoxaluria (Oxaluria) 05/2013 - 12/2009
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 11/2021
2	Hypocalcemia 07/2021 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2017 - 02/2011
2	Bone Resorption 01/2017 - 09/2014
2	Necrosis 01/2015 - 09/2012
2	Crystalluria 05/2013 - 12/2009
2	Familial Hypophosphatemia (Phosphate Diabetes) 01/2007 - 01/2005
1	Calciphylaxis 10/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2020
1	Chronic Kidney Diseases of Uncertain Etiology 01/2020
1	Dehydration (Water Stress) 01/2020
1	Acute-Phase Reaction 01/2019

Drug/Important Bio-Agent (IBA)

17	Phosphates (Orthophosphate)IBA 10/2020 - 03/2004
15	CalciumIBA 01/2020 - 03/2003
12	MineralsIBA 04/2022 - 03/2003
10	lanthanum carbonate (Fosrenol)FDA Link 01/2014 - 06/2003
8	Adenine FDA LinkGeneric 01/2022 - 06/2009
6	LanthanumIBA 02/2009 - 03/2004
5	Parathyroid Hormone (Parathormone)IBA 01/2021 - 03/2003
5	calcium phosphateIBA 01/2020 - 06/2009
5	Biomarkers (Surrogate Marker)IBA 11/2019 - 05/2003
5	CollagenIBA 11/2019 - 01/2010
5	Proteins (Proteins, Gene)FDA Link 12/2018 - 01/2009
5	Sevelamer (RenaGel)FDA Link 11/2016 - 01/2005
5	Vitamin D FDA LinkGeneric 01/2014 - 05/2006
5	StrontiumIBA 01/2011 - 01/2003
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2012
4	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 01/2018
4	CreatinineIBA 07/2021 - 03/2003
4	Alkaline PhosphataseIBA 07/2021 - 05/2003
4	Biological ProductsIBA 01/2020 - 09/2010
3	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2018
3	Ethylene Glycol (Monoethylene Glycol)IBA 01/2020 - 01/2009
3	Calcium Carbonate (Limestone)FDA Link 01/2014 - 06/2003
3	MagnesiumIBA 01/2014 - 06/2012
3	Calcium OxalateIBA 05/2013 - 08/2010
3	Phosphorus (Red Phosphorus)IBA 11/2012 - 03/2003
3	strontium ranelate (protelos)IBA 03/2005 - 08/2003
3	ElementsIBA 07/2004 - 03/2003
2	EnzymesIBA 07/2021 - 01/2020
2	diphosphoric acid (pyrophosphoric acid)IBA 01/2020 - 11/2016
2	SBI-425IBA 01/2020 - 01/2020
2	salicylhydroxamic acid (SHAM)IBA 01/2018 - 01/2011
2	Cinacalcet (Sensipar)FDA Link 04/2015 - 11/2012
2	Dipeptidyl-Peptidase IV InhibitorsIBA 09/2014 - 09/2012
2	calcium acetate (Phoslo)FDA LinkGeneric 01/2014 - 06/2013
2	magnesium carbonate (magnesite)FDA Link 01/2014 - 06/2013
2	OxalatesIBA 05/2013 - 12/2011
2	Phenobarbital (Luminal)FDA Link 12/2009 - 10/2005
2	OsteopontinIBA 12/2009 - 10/2005
2	Hyaluronic Acid (Hyaluronan)IBA 12/2009 - 10/2005
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2008 - 09/2004
2	AluminumIBA 07/2004 - 03/2004
1	SodiumIBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	CanagliflozinIBA 01/2022
1	NAD (NADH)IBA 11/2021
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 11/2021
1	Tetracycline (Achromycin)FDA LinkGeneric 11/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	sucroferric oxyhydroxideIBA 10/2020
1	SNF472IBA 10/2020
1	MicroRNAs (MicroRNA)IBA 05/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020
1	Inositol PhosphatesIBA 01/2020
1	IonsIBA 01/2020
1	Phytic Acid (Inositol Hexaphosphate)IBA 01/2020
1	Calcineurin InhibitorsIBA 01/2020
1	Poly Adenosine Diphosphate RiboseIBA 11/2019
1	Liver X ReceptorsIBA 01/2019
1	romosozumabIBA 01/2019

Therapy/Procedure

6	Therapeutics 10/2020 - 03/2009
5	Nephrectomy 01/2018 - 01/2005
3	Kidney Transplantation 02/2020 - 01/2011
3	Transplantation 12/2018 - 01/2009
2	Renal Dialysis (Hemodialysis) 01/2017 - 10/2009
2	Protein-Restricted Diet (Diet, Protein Restricted) 11/2016 - 09/2010